Updated 04:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,051.60 -0.56% CL 102.78 +2.88% BTC 79,693.74 -1.38%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,052 −0.56% BTC $79,694 −1.38% VIX 16.91 −3.48% latest tape · as of 04:01 UTC
The Screen · Financials

Direxion Daily XOM Bull 2X ETF

XOMX · USD

The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of XOM and financial instruments, such as swap agreements and options, that, in…

FAIL · Does not pass the screen
59.95 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago

Screened 2026-10-23 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price59.95 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • Last reviewed23 Oct 2026 (6 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 59.95 against the desk's fair-value range, over the last year.

Current read
Accumulation ?
Screened · screened 2026-10-23
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price59.95 USD
Ethical score30.0/100
Our investment reviews on this name
2026-10-18Read Accumulation56.27+6.5% to today ✓Markup gives way to Accumulation after a 24% rise in 7 days
2026-10-11Read Markup45.37+32.1% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution45.37+32.1% to today Accumulation gives way to Distribution after a 12% rise in 2 weeks
2026-09-17Read Accumulation40.56+47.8% to today ✓Markup gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Direxion Daily XOM Bull 2X ETF holds its Accumulation at $59.95. Elevated stress, defensive posture warranted, held for 1 days.

As held on the ledger · 2026-10-23
PhaseAccumulation
Quantitative stateElevated stress, defensive posture warranted, held for 1 days
Price at the screen$59.95
Valuation24.72 trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
The Workings

Five Screens, Shown in Full

Does not pass. Financial sector: Financial

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: Financial Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Direxion Daily XOM Bull 2X ETF does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when XOMX's ethical verdict changes

Today XOMX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E24.7xa premium valuation
Dividend yield165.00%
52-week range23.00 - 60.28

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-18 Accumulation · changed $56.27 +24.0% Entry 8

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 24.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-10-11 Markup · changed $45.37 +0.0% Entry 7

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-10-02 Distribution · changed $45.37 +11.9% Entry 6

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 11.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-09-17 Accumulation · changed $40.56 +0.0% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-08-18 Markup · changed $40.56 +0.0% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-07-18 Distribution $40.56 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 40%.

2026-07-03 Distribution $40.56 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Distribution $40.56 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $42.32 +1.6% · $1,016 +1.6%
2 months $44.47 -3.3% · $967 -3.3%
3 months $45.95 -6.4% $0.16 $940 -6.0%
6 months $28.65 +50.1% $0.35 $1,513 +51.3%
1 year $23.91 +79.9% $0.66 $1,826 +82.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever XOMX does next, these words stay.

Direxion Daily XOM Bull 2X ETF · XOMX · Accumulation · $59.95
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.